US Patent Issued to The Regents of the University of California on Sept. 2 for "Dosage of claudin-6 conjugates for cancer treatment" (California Inventors)

ALEXANDRIA, Va., Sept. 3 -- United States Patent no. 12,403,202, issued on Sept. 2, was assigned to The Regents of the University of California (Oakland, Calif.).

"Dosage of claudin-6 conjugates for cancer treatment" was invented by Dennis Slamon (Los Angeles) and Neil A. O'Brien (Los Angeles).

According to the abstract* released by the U.S. Patent & Trademark Office: "Described herein are methods for inhibiting a solid tumor expressing claudin-6 in a human subject, comprising administering to the human subject an effective amount of a composition comprising conjugates of a CLDN6-specific antigen-binding protein covalently bound to heterologous moieties comprising structural formula (I): wherein a first plurality of the conjugates are bou...